Dr. Janbain is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1430 Tulane Ave
Slip 78
New Orleans, LA 70112Phone+1 504-988-5482Fax+1 504-988-5483
Education & Training
Lebanese University School of MedicineClass of 2005
Certifications & Licensure
LA State Medical License 2012 - 2025
OH State Medical License 2007 - 2012- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Real-world impact of emicizumab and immunosuppression on acquired hemophilia A: a multicenter US cohort.Jacqueline N Poston, Cassandra Bryan, Annette von Drygalski, Kadhim Al Banaa, Jenny Y Zhou
Blood Advances. 2024-11-26 - 2 citationsMulticenter evaluation of the hemostatic activity of emicizumab in patients with severe hemophilia A.Laurie Josset, Alexandre Leuci, Maissaa Janbain, Anaëlle De-Wreede, Stephanie Desage
Journal of Thrombosis and Haemostasis. 2024-07-01 - Interim analyses of the multinational real-world prospective cohort HEM-POWR study evaluating the effectiveness and safety of damoctocog alfa pegol in patients with he...Mark T Reding, María Teresa Álvarez-Román, Giancarlo Castaman, Maissaa Janbain, Tadashi Matsushita
European Journal of Haematology. 2024-02-01
Press Mentions
Louisiana Center for Bleeding and Clotting Disorders Strengthens Partnership with Guyana’s Hemophilia Treatment CenterOctober 10th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
